Julie Giurintano

ORCID: 0000-0002-7104-3900
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Respiratory Support and Mechanisms
  • Airway Management and Intubation Techniques
  • Infection Control and Ventilation
  • COVID-19 Clinical Research Studies
  • Autoimmune and Inflammatory Disorders Research
  • SARS-CoV-2 and COVID-19 Research
  • Insect Resistance and Genetics
  • Nosocomial Infections in ICU
  • Mycobacterium research and diagnosis
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory viral infections research
  • Cardiac Arrest and Resuscitation
  • Entomopathogenic Microorganisms in Pest Control
  • Pneumothorax, Barotrauma, Emphysema
  • Tracheal and airway disorders
  • Adolescent and Pediatric Healthcare
  • Transplantation: Methods and Outcomes
  • COVID-19 and healthcare impacts
  • Long-Term Effects of COVID-19
  • Insect Pest Control Strategies
  • Immunodeficiency and Autoimmune Disorders

Temple University
2020-2022

Temple University Hospital
2021

Invasive mechanical has been associated with high mortality in COVID-19. Alternative therapy of flow nasal (HFNT) greatly debated around the world for use COVID-19 pandemic due to concern increased healthcare worker transmission.This was a retrospective analysis consecutive patients admitted Temple University Hospital Philadelphia, Pennsylvania, from 10 March 2020 24 April moderate-to-severe respiratory failure treated HFNT. Primary outcome prevention intubation. Of 445 COVID-19, 104 met our...

10.1136/bmjresp-2020-000650 article EN cc-by-nc BMJ Open Respiratory Research 2020-08-01

Abstract Ascaroside pheromones stimulate dispersal, a key nematode behavior to find new food source. Ascarosides produced by entomopathogenic nematodes (EPNs) drive infective juvenile (IJ) emergence from consumed cadavers and dispersal in soil. Without ascarosides host cadavers, Steinernema feltiae (EPN) reduce substantially. To determine whether other spp. exhibit the same behavior, we compared S. carpocapsae IJs without cadaver pheromones. Unlike , continued disperse. However, exhibited...

10.1038/s41598-020-62817-y article EN cc-by Scientific Reports 2020-03-31

Background: Most safety and efficacy trials of the SARS-CoV-2 vaccines excluded patients with cancer, yet these are more likely than healthy individuals to contract become seriously ill after infection. Our objective was record short-term adverse reactions COVID-19 vaccine in compare magnitude duration those without determine whether related active cancer therapy. Patients Methods: A prospective, single-institution observational study performed at an NCI-designated Comprehensive Cancer...

10.6004/jnccn.2021.7113 article EN Journal of the National Comprehensive Cancer Network 2022-02-01

The use of high-flow nasal therapy (HFNT) to treat COVID-19 pneumonia has been greatly debated around the world due concerns about increased health care worker transmission and delays in invasive mechanical ventilation (IMV). Herein, we analyzed utility noninvasive ROX (ratio oxygen saturation) index predict need for timing IMV.This study aimed assess whether can be a useful score intubation IMV patients receiving HFNT as treatment COVID-19-related hypoxemic respiratory failure.This is...

10.2196/29062 article EN cc-by JMIRx Med 2021-06-04

Abstract Use of high flow nasal therapy (HFNT) to treat COVID-19 pneumonia has been greatly debated around the world due concern for increased healthcare worker transmission and delays in invasive mechanical Ventilation (IMV). Methods A retrospective analysis consecutive patients admitted Temple University Hospital Philadelphia, Pennsylvania, from March 10, 2020, May 17, 2020 with moderate severe respiratory failure treated High Flow (HFNT). HFNT were divided into two groups: only progressed...

10.1101/2020.06.30.20143867 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-02

Abstract Invasive mechanical has been associated with high mortality in COVID-19. Alternative therapy of High flow nasal (HFNT) greatly debated around the world for use COVID-19 pandemic due to concern increased healthcare worker transmission. Methods This was a retrospective analysis consecutive patients admitted Temple University Hospital Philadelphia, Pennsylvania, from March 10, 2020, April 24, 2020 moderate severe respiratory failure treated Flow (HFNT). Primary outcome prevention...

10.1101/2020.05.22.20109355 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-05-26

Abstract Background Lung transplant patients (LTPs) experience considerable infection-related morbidity and mortality, including from pneumonia. Our institution performs the highest volume of lung transplants in US, providing an opportunity to describe scope impact pneumonia LTPs. Methods We conducted a retrospective cohort study all who received at our late 2017 early 2020. Patient records were reviewed pre-transplant period 1-year after for data pertinent comorbidities, transplantation...

10.1093/ofid/ofac492.1738 article EN cc-by Open Forum Infectious Diseases 2022-12-01

<sec> <title>BACKGROUND</title> The use of high-flow nasal therapy (HFNT) to treat COVID-19 pneumonia has been greatly debated around the world due concerns about increased health care worker transmission and delays in invasive mechanical ventilation (IMV). Herein, we analyzed utility noninvasive ROX (ratio oxygen saturation) index predict need for timing IMV. </sec> <title>OBJECTIVE</title> This study aimed assess whether can be a useful score intubation IMV patients receiving HFNT as...

10.2196/preprints.29062 preprint EN cc-by 2021-03-24
Coming Soon ...